How can our values and expectations help us make the right choices? While GSK’s written standards help all of us address the significant risks we face, it’s not possible to cover every eventuality. What to keep in mind when taking action or making a decision: • Our values and expectations • Appropriate regulations, standards and laws
Purpose, strategy and culture - GSK
We’re confident in our future. Our bold ambitions for patients are reflected in our upgraded growth outlooks to 2026 and 2031. This means more GSK vaccines and medicines, including innovative new products, will reach more people who need them than ever before. Investors
Purpose, strategy and culture | GSK US
Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. GSK is a company where outstanding people can thrive. We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to …
New GSK to deliver step-change in growth and performance over …
Jun 23, 2021 · At an update to investors today, GlaxoSmithKline plc (GSK LSE & NYSE) will provide details of its strategy, outlook for growth and plans to create shareholder value, following the planned demerger in mid-2022 of its Consumer Healthcare business.
Turning now to New GSK. With new ambition comes new purpose. For New GSK this is to unite science, talent and technology to get ahead of disease together- all with the clear ambition of delivering human health impact; stronger and more sustainable shareholder returns; and as a new GSK where outstanding people thrive.
‘The Tesla of pharma’: GSK on the strategy behind its rebrand
Jun 9, 2022 · GSK’s new purpose is to ‘unite science, talent and technology to get ahead of disease together’. Or more succinctly, ‘Ahead Together’. “This really captures the collaboration both internally – working with diverse people in teams – and externally.
Purpose, strategy and culture | GSK Canada
GSK has changed. In July 2022, we demerged our world-leading consumer healthcare business, Haleon. We are now a fully focused biopharma company. We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease.
New GSK to deliver step-change in growth and performance
Jun 25, 2021 · GlaxoSmithKline has announced New GSK, which will deliver step-change in growth and performance over next ten years, driven by a high-quality Vaccines and Specialty Medicines portfolio and late-stage pipeline. New GSK will keep a 20% stake in the consumer healthcare business.
At GSK, we put our values at the heart of every decision we make. Our values guide our day-to-day actions – no matter what. Because we believe that it’s not just what we achieve that counts, it’s also how we achieve it. Contents Q. Who should follow our Code of Conduct? A. Everyone who works for GSK Speak up if you identify anything of ...
What’s Next for the New GSK After Consumer Healthcare Spin-off?
Jul 21, 2022 · The new company, operates across five product segments: (1) oral health, which represented 29% of the business’ FY 2021 revenues of £9.5 billion ($11.4 billion); (2) pain relief, 23%; (3) digestive health and other, 20%; (4) vitamins, minerals, and supplements, 16%; and (5) respiratory health, 12%.